These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Recommendations for utilizing computerized tomography and magnetic resonance tomography in heart diagnosis. 2--Magnetic resonance tomography ]. Lotz J; Kivelitz D; Fischbach R; Beer M; Miller S Rofo; 2009 Aug; 181(8):800-14. PubMed ID: 19621277 [TBL] [Abstract][Full Text] [Related]
24. Dynamic cardiac MR imaging. Techniques and applications. Pettigrew RI Radiol Clin North Am; 1989 Nov; 27(6):1183-203. PubMed ID: 2685881 [TBL] [Abstract][Full Text] [Related]
25. [MR contrast media for cardiovascular imaging]. Krombach GA; Higgins CB; Günther RW; Kühne T; Saeed M Rofo; 2002 Jul; 174(7):819-29. PubMed ID: 12101470 [TBL] [Abstract][Full Text] [Related]
26. Gadolinium-based magnetic resonance imaging contrast agents in interventional radiology. Atar E Isr Med Assoc J; 2004 Jul; 6(7):412-4. PubMed ID: 15274532 [TBL] [Abstract][Full Text] [Related]
27. MRI in ischemic heart disease: expansion of the current capabilities with MR contrast. Higgins CB; Saeed M; Wendland M Am J Card Imaging; 1991 Mar; 5(1):38-50. PubMed ID: 10147583 [TBL] [Abstract][Full Text] [Related]
28. How to plan and perform a cardiac MR imaging examination. Poustchi-Amin M; Gutierrez FR; Brown JJ; Mirowitz SA; Narra VR; Takahashi N; McNeal GR; Woodard PK Radiol Clin North Am; 2004 May; 42(3):497-514, v. PubMed ID: 15193927 [TBL] [Abstract][Full Text] [Related]
29. New directions in cardiac magnetic resonance imaging. Zerhouni EA Top Magn Reson Imaging; 1990 Mar; 2(2):67-71. PubMed ID: 2331381 [TBL] [Abstract][Full Text] [Related]
30. 3.0 T neuroimaging: technical considerations and clinical applications. Willinek WA; Kuhl CK Neuroimaging Clin N Am; 2006 May; 16(2):217-28, ix. PubMed ID: 16731361 [TBL] [Abstract][Full Text] [Related]
31. Tumor models and specific contrast agents for small animal imaging in oncology. Ni Y; Wang H; Chen F; Li J; DeKeyzer F; Feng Y; Yu J; Bosmans H; Marchal G Methods; 2009 Jun; 48(2):125-38. PubMed ID: 19328231 [TBL] [Abstract][Full Text] [Related]
32. Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography. Stabi KL; Bendz LM Ann Pharmacother; 2011 Dec; 45(12):1571-5. PubMed ID: 22045905 [TBL] [Abstract][Full Text] [Related]
33. Congenital cardiovascular malformations: noninvasive imaging by MRI in neonates. Krishnamurthy R; Lee EY Magn Reson Imaging Clin N Am; 2011 Nov; 19(4):813-22; viii. PubMed ID: 22082739 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular applications of phase-contrast MRI. Srichai MB; Lim RP; Wong S; Lee VS AJR Am J Roentgenol; 2009 Mar; 192(3):662-75. PubMed ID: 19234262 [TBL] [Abstract][Full Text] [Related]
36. Contrast agents for cardiovascular magnetic resonance imaging. Current status and future directions. Schalla S; Higgins CB; Saeed M Drugs R D; 2002; 3(5):285-302. PubMed ID: 12455148 [TBL] [Abstract][Full Text] [Related]
37. Cardiac drugs used in cross-sectional cardiac imaging: what the radiologist needs to know. McParland P; Nicol ED; Harden SP Clin Radiol; 2010 Sep; 65(9):677-84. PubMed ID: 20696294 [TBL] [Abstract][Full Text] [Related]
38. Cardiac magnetic resonance: impact on diagnosis and management of patients with congenital cardiovascular disease. Secchi F; Di Leo G; Papini GD; Nardella VG; Negura D; Carminati M; Sardanelli F Clin Radiol; 2011 Aug; 66(8):720-5. PubMed ID: 21570066 [TBL] [Abstract][Full Text] [Related]